Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 1.11M | 0.55% | $ 203.47M |
3/31/2025 | $ 919K | 0.46% | $ 201.35M |
12/31/2024 | $ 490K | 0.25% | $ 198.77M |
9/30/2024 | $ 529K | 0.28% | $ 190.86M |
6/30/2024 | $ 392K | 0.22% | $ 182.02M |
3/31/2024 | $ 339K | 0.19% | $ 177.6M |
12/31/2023 | $ 383K | 0.2% | $ 192.64M |
9/30/2023 | $ 393K | 0.19% | $ 211.85M |
6/30/2023 | $ 517K | 0.22% | $ 238.35M |
3/31/2023 | $ 655K | 0.26% | $ 256.69M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / Revenues
(=) CapEx %
CapEx % for VANDA PHARMACEUTICALS INC is calculated as follows: CapEx [ $ 897K ] / Revenues [ $ 241.44M ]
(=) CapEx % [ 0.37% ]
Minimum
Jun 30, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.85K |
---|---|
min | 0% |
max | 15.04% |
average | 3.46% |
median | 2.43% |
std | 3.27% |